📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/gt.2016.66

PubMed Identifier: 27653967

Publication URI: http://europepmc.org/abstract/MED/27653967

Type: Journal Article/Review

Volume: 23

Parent Publication: Gene therapy

Issue: 12

ISSN: 0969-7128